Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of Exclusive Agreement with Nouryon

15 Nov 2022 07:00

RNS Number : 3654G
Quadrise Fuels International PLC
15 November 2022
 

15 November 2022

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

Extension of Exclusive Agreement with Nouryon

 

Quadrise (AIM:QFI), the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, is pleased to announce the extension of the Exclusive Global Collaboration and Emulsifiers Sales Agreement ("Agreement") with Nouryon, a global specialty chemicals leader, for the exclusive supply of goods, services and IP for future MSAR® and bioMSAR™ projects. The Agreement, the terms of which were announced on 8 October 2019, will now run for a further three years to October 2025.

 

Commenting on the Agreement, Jason Miles, CEO of Quadrise, said:

"We are delighted to have extended our long-standing and successful collaboration with Nouryon for a further three years. This extension reinforces the commitment of both parties to commercialising Quadrise's proprietary fuels and biofuels, providing more sustainable and economical solutions for the energy and marine sectors."

Commenting on the Agreement Joppe Smit, Vice President of Natural Resources and Intermediates for Nouryon, said:

"Working closely with our customers to support the decarbonisation journey of key industries like marine and power generation is a key part of our strategy. The extension of our long-standing partnership with Quadrise is an example of the collaboration and innovation required to tackle world's energy transition challenges. It also reiterates Nouryon's commitment to consistently provide sustainable solutions to our customers globally."

Background to the Nouryon Agreement:

The Agreement between Quadrise International Limited ("QIL"), a subsidiary of the Company, and Nouryon Surface Chemistry AB ("NSC") continues the commercial relationship between the parties relating to the purchase and supply of goods and associated technical services to MSAR® and bioMSAR™ projects in development. QIL purchases, and will continue to purchase, speciality chemicals used as emulsifiers exclusively from NSC, which NSC supplies exclusively to QIL for oil-in-water emulsion fuel and biofuel applications.

Intellectual Property arising from any future joint development activity, or relating to past work such as MSAR® and bioMSAR™ development, is jointly owned between the parties in agreed territories. The Agreement is exclusive in the field of oil-in-water emulsion fuels and biofuels research and development unless otherwise agreed jointly.

 

For further information please contact:

Quadrise Fuels International Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Broker

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs

Fiona Conroy

Public & Investor Relations

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

Nouryon

Regina Tracy

Head of Communications, Performance Formulations and the Americas

 

+1-484-745-5414

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

Learn more at www.quadrisefuels.com, @QFIPLC and on LinkedIn.

 

About Nouryon

Nouryon is a global, specialty chemicals leader. Markets and consumers worldwide rely on our essential solutions to manufacture everyday products, such as personal care, cleaning goods, paints and coatings, agriculture and food, pharmaceuticals, and building products. Furthermore, the dedication of more than 7,650 employees with a shared commitment to our customers, business growth, safety, sustainability and innovation has resulted in a consistently strong financial performance. They operate in over 80 countries around the world with a portfolio of industry-leading brands.

 

Learn more at www.nouryon.com, @Nouryon and on LinkedIn.

 

 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDZLFFLFLEFBK
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.